Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Influenza
Research
'Active' vaccine adjuvant boosts COVID, flu antibodies in mice
Researchers think they may have found one of the most potent adjuvants so far: an immunomodulating small molecule called PVP-037.
Helen Floersh
Jul 9, 2024 4:00am
Moderna flu/COVID beats immune responses for approved shots
Jun 10, 2024 6:30am
Cidara regains rights to flu med from Janssen, divests Rezzayo
Apr 24, 2024 4:05pm
GSK, Vir end flu drug alliance, removing key piece of $345M pact
Feb 23, 2024 5:10am
Veru needs cash for fresh trial of respiratory distress drug
Feb 8, 2024 10:45am
GSK tips 12 blockbuster launches to soften HIV patent loss
Jan 31, 2024 7:45am